US2016158026A9PendingUtilityA9

Devices and Methods for Tissue Engineering

Assignee: BIO2 TECHNOLOGIES INCPriority: Jul 10, 2009Filed: Feb 14, 2014Published: Jun 9, 2016
Est. expiryJul 10, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:James Jenq Liu
Y10T428/249928A61F 2210/0004A61F 2/30734A61L 27/54A61F 2310/00329A61F 2/4465A61F 2002/4495A61F 2002/30062A61L 27/10A61L 27/56A61L 2430/38A61F 2/28A61F 2/3094A61L 2430/02A61L 2400/18C03C 2213/02C03C 2204/00C03C 4/0014A61F 2/02A61F 2002/3092C03C 11/00A61L 27/58A61F 2/44C03C 13/006A61F 2002/30968C03C 10/0009
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A resorbable tissue scaffold fabricated from bioactive glass fiber forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the bioactive glass fiber in the porous matrix. Strength of the bioresorbable matrix is provided by bioactive glass that fuses and bonds the bioactive glass fiber into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A spinal implant comprising:
 a body having a height sized for engagement within a space between adjacent vertebrae;   the body having a composition that is formed essentially of bioactive glass fibers sintered into a porous structure; and   the body adapted to be inserted into the space between adjacent vertebrae wherein the body facilitates an ingrowth of tissue to promote fusion and wherein the body is resorbable.   
     
     
         2 . The spinal implant according to  claim 1  wherein the height is greater than the space between adjacent vertebrae. 
     
     
         3 . The spinal implant according to  claim 1  wherein the bioactive glass fibers include a crystalline phase. 
     
     
         4 . The spinal implant according to  claim 1  wherein the bioactive glass fibers have a composition comprising mol % quantities of 6% Na 2 O; 7.9% K 2 O; 7.7% MgO; 22.1% CaO; 1.7% P 2 O 5 ; and 54.6% SiO 2 . 
     
     
         5 . The spinal implant according to  claim 1  wherein the body has a porosity that is greater than 50% and a compressive strength that is greater than 22 MPa. 
     
     
         6 . The spinal implant according to  claim 1  wherein the bioactive glass fibers have a plurality of compositions. 
     
     
         7 . The spinal implant according to  claim 1  wherein the porous structure further comprises bioactive glass coating the bioactive glass fibers.

Join the waitlist — get patent alerts

Track US2016158026A9 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.